PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm

Patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) have poor outcomes despite intensive chemotherapy, underscoring the need for novel therapeutic approaches. The expression status of PD1/PD-L1 in BPDCN remains unknown. We evaluated PD1/PD-L1 by immunohistochemistry and RNAseq express...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Aung, Phyu P., Sukswai, Narittee, Nejati, Reza, Loghavi, Sanam, Chen, Weina, Torres-Cabala, Carlos A., Yin, C. Cameron, Konopleva, Marina, Zheng, Xiaofeng, Wang, Jing, Tang, Zhenya, Medeiros, L. Jeffrey, Prieto, Victor G., Pemmaraju, Naveen, Khoury, Joseph D.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562447/
https://ncbi.nlm.nih.gov/pubmed/31109153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050695
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados